{"organizations": [], "uuid": "b3ad775f17bb76a6de54061081f21f3f513dd6c8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Pharma-ADMET-Testing-3A-World-Industry-and-Market-Prospects-2015-2025-48811-1/", "country": "US", "title": "Pharma ADMET Testing: World Industry and Market Prospects 2015-2025", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Pharma ADMET Testing: World Industry and Market Prospects 2015-2025", "spam_score": 0.0, "site_type": "news", "published": "2015-10-12T16:35:00.000+03:00", "replies_count": 0, "uuid": "b3ad775f17bb76a6de54061081f21f3f513dd6c8"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Pharma-ADMET-Testing-3A-World-Industry-and-Market-Prospects-2015-2025-48811-1/", "ord_in_thread": 0, "title": "Pharma ADMET Testing: World Industry and Market Prospects 2015-2025", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "A company profile gives you the following information where available:• Recent historical revenues• Discussion of a company's activities, technologies and outlook• Brief assessment of the company's ADMET strategy. \nWith that information you will assess competitors' capabilities, progress, and commercial prospects, helping you stay ahead and benefit your reputation for insight. \nNational markets for those drug development technologies Our study shows you prospects for ADMET sales in developed and developing countries. You will see individual revenue forecasts to 2025 for 12 countries:• United States • Germany , France , United Kingdom , Italy and Spain (EU5)• Brazil , Russia , India and China (BRIC)• South Korea . \nWith our analysis you will investigate regions with highest revenues, demand and potential sales. Explore progress, needs and opportunities, seeing how you can gain. \nWhat forces affect the pharma ADMET testing industry? Our new report discusses issues and events affecting the pharmaceutical ADMET testing industry and market. You will find discussions, including qualitative analyses:• Rising demand for early ADMET testing• Developments in that drug screening technology. \nYou will see discussions of technological, commercial, and economic issues, with emphasis on the competitive landscape and business outlooks. Discover what the future holds. \nHow Pharma ADMET Testing: World Industry and Market Prospects 2015-2025 helps In particular, our new investigation gives the following knowledge to benefit your work:• Revenue forecasts to 2025 for the pharma ADMET testing market - discover that industry's commercial prospects, finding what revenues and growth are possible• Revenue forecasts to 2025 for three submarkets - explore sales potentials of in vitro, in vivo and in silico testing• Revenue forecasts to 2025 for 12 leading national markets - US, EU5 ( Germany , France , UK, Italy and Spain ), Japan , Brazil , Russia , India , China and South Korea • Assessment of leading companies - assess competitors, exploring their product and service portfolios, strategic developments and commercial outlooks• Exclusive interviews with three companies - gain opinions from MultiCASE Inc., Optivia Biotechnology and Takara Bio Europe AB, seeing what participants say and do• Discussion of what stimulates and restrains companies and the market - examine forces affecting those technologies and their providers• Prospects for established firms and those seeking to enter the industry - discover what the future holds, helping you stay ahead in knowledge. \nThere you will find quantitative and qualitative analyses with independent predictions. That way you will receive information that only our report contains, staying informed on business intelligence. \nData and discussions found nowhere else, helping your research, analyses and decisions With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight. \nVisiongain 's new study is for everybody needing analyses of the pharma ADMET testing market and that industry's leading companies. There you will find data, trends and predictions. Stay ahead by getting that report here now. \nTo see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com \nTo request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100 \nOr click on https://www.visiongain.com/Report/1512/Pharma-ADMET-Testing-World-Industry-and-Market-Prospects-2015-2025 \nAbD Serotec (now part of Bio-Rad Laboratories) ACEA Biosciences", "external_links": [], "published": "2015-10-12T16:35:00.000+03:00", "crawled": "2015-10-12T16:37:48.801+03:00", "highlightTitle": ""}